Filing Details

Accession Number:
0001209191-23-055663
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-11-17 12:36:50
Reporting Period:
2023-11-16
Accepted Time:
2023-11-17 12:36:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
818033 Heron Therapeutics Inc. HRTX Pharmaceutical Preparations (2834) 942875566
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1488864 Ira Duarte 4242 Campus Point Court, Suite 200
San Diego CA 92121
Evp, Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-11-16 85,000 $0.89 85,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The range of purchase prices paid was $0.8708 to $0.9201. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased at each separate price.